Fdc Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of FDC Ltd is ₹ 364.7 as of 30 Apr 15:30 . The P/E Ratio of FDC Ltd changed from 16 on March 2021 to 24.1 on March 2025 . This represents a CAGR of 8.54% over 5 yearsThe P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of FDC Ltd changed from ₹ 4822 crore on March 2021 to ₹ 6419 crore on March 2025 . This represents a CAGR of 5.89% over 5 yearsThe Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of FDC Ltd for the Dec '25 is ₹ 485.51 crore as compare to the Sep '25 revenue of ₹ 493.66 crore. This represent the decline of -1.65% The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of FDC Ltd for the Dec '25 is ₹ 52.29 crore as compare to the Sep '25 ebitda of ₹ 54.44 crore. This represent the decline of -3.95% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of FDC Ltd changed from ₹ 119.04 crore to ₹ 28.3 crore over 7 quarters. This represents a CAGR of -56.00% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of FDC Ltd changed from 29.75 % on March 2025 to 29.75 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About FDC Ltd

FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
It has established a global footprint in both domestic and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry. Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

FAQs for the comparison of FDC Ltd and Krebs Biochemicals & Industries Ltd

Which company has a larger market capitalization, FDC Ltd or Krebs Biochemicals & Industries Ltd?

Market cap of FDC Ltd is 5,937 Cr while Market cap of Krebs Biochemicals & Industries Ltd is 129 Cr

What are the key factors driving the stock performance of FDC Ltd and Krebs Biochemicals & Industries Ltd?

The stock performance of FDC Ltd and Krebs Biochemicals & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for FDC Ltd and Krebs Biochemicals & Industries Ltd?

As of May 3, 2026, the FDC Ltd stock price is INR ₹364.7. On the other hand, Krebs Biochemicals & Industries Ltd stock price is INR ₹60.12.

How do dividend payouts of FDC Ltd and Krebs Biochemicals & Industries Ltd compare?

To compare the dividend payouts of FDC Ltd and Krebs Biochemicals & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.